Old Web
English
Sign In
Acemap
>
authorDetail
>
Prasad Nadella
Prasad Nadella
AstraZeneca
Biology
Cancer
Immunology
Mitotic catastrophe
Poly ADP ribose polymerase
4
Papers
1
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract A93: STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment
2015
Cancer immunology research
Rich Woessner
Patricia McCoon
Kirsten Bell
Rachel DuPont
Michael Collins
Deborah Lawson
Prasad Nadella
Lourdes Pablo
Corinne Reimer
Vasu Sah
Paul Lyne
Show All
Source
Cite
Save
Citations (0)
Abstract B150: Identifying tolerable schedules for targeted anti-cancer agents by applying ordered logistic regression modeling to empirical pathology scores in mice
2015
Molecular Cancer Therapeutics
Francis D. Gibbons
Shenghua Wen
Prasad Nadella
Show All
Source
Cite
Save
Citations (0)
501 Immunological STAT3 knockdown associated with anti-tumor activity in pre-clinical models translates to clinical samples, suggesting immune modulation contributes to the clinical activity of AZD9150, a therapeutic STAT3 ASO
2014
European Journal of Cancer
Patricia McCoon
Rich Woessner
Rachel DuPont
Kirsten Bell
Michael Collins
Lourdes Pablo
Deborah Lawson
Prasad Nadella
V Jacobs
Chris Womack
Corinne Reimer
David S. Hong
John Nemunaitis
Y K Kang
T. Y. Kim
H. Y. Lim
T. Okusaka
S. Nadano
C. C. Lin
Paul Lyne
Show All
Source
Cite
Save
Citations (0)
Abstract A221: Novel PARP6 inhibitors demonstrate in vivo efficacy in xenograft models.
2013
Molecular Cancer Therapeutics
Michele Mayo
Shaun Grosskurth
Xin Wang
Philip Petteruti
Prasad Nadella
Corinne Reimer
Keith Mikule
Show All
Source
Cite
Save
Citations (1)
1